Sandoz Estimates Potential Canadian Savings From Generics and Biosimilars
Sandoz estimates that generics and biosimilars could generate savings in Canada by 2035.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.